Related Experiment Video
Updated: Aug 11, 2026

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
Published on: June 25, 2010
Serum alkaline phosphatase and urinary hydroxyproline values in children receiving phenobarbital with and without
Insights
Phenobarbital use in children receiving anticonvulsants may increase rickets risk by altering bone metabolism markers. Daily vitamin D supplementation appears crucial for preventing or reversing these biochemical changes.
Area of Science:
- Pediatric Endocrinology
- Clinical Pharmacology
- Biochemistry
Background:
- Anticonvulsive medications are frequently prescribed for prolonged periods in children.
- Concerns exist regarding the potential skeletal side effects of long-term anticonvulsant therapy, specifically rickets.
- Phenobarbital is a commonly used anticonvulsant with a known impact on vitamin D metabolism.
Purpose of the Study:
- To investigate the effect of phenobarbital on biochemical markers associated with rickets development in children on long-term anticonvulsant therapy.
- To assess the efficacy of vitamin D supplementation in mitigating phenobarbital-induced biochemical derangements.
Main Methods:
- Serum alkaline phosphatase (AP) and total urinary hydroxyproline (HOP) levels were measured in 36 children.
- Children were receiving anticonvulsive medications, with a focus on phenobarbital administration.
- Intervention included a single large dose of vitamin D and a two-month daily regimen of 4,000 IU vitamin D.
Main Results:
- Phenobarbital administration rapidly increased AP and HOP values, indicating early biochemical changes suggestive of rickets, even without overt bone abnormalities.
- A single large oral dose of vitamin D did not correct these biochemical alterations.
- Daily vitamin D (4,000 IU for two months) effectively prevented or reversed latent rickets changes in children on anticonvulsants.
Conclusions:
- Phenobarbital administration is strongly implicated in the development of rickets in children undergoing long-term anticonvulsant treatment.
- Daily vitamin D supplementation is essential for children receiving anticonvulsive drugs to prevent or manage rickets.
- Monitoring bone metabolism and ensuring adequate vitamin D intake are critical in this patient population.
Abstract:
Concentrations of serum alkaline phosphatase and total urinary hydroxyproline were measured in 36 children to study the effect of phenobarbital administration with respect to the development of rickets in patients receiving anticonvulsive medications over prolonged periods of time. Administration of phenobarbital led to the appearance of increased AP and HOP values very early in the course of treatment and without any obvious bone changes suggestive of rickets; a single large oral dose of vitamin D had no appreciable effects in restoring the biochemical derangement. On the other hand, the administration of vitamin D in a daily dose of 4,000 IU for a period of two months hampered the appearance, or restored already existing changes of latent rickets, in children receiving anticonvulsive medication. The results in the present study favor the concept that phenobarbital administration is implicated in the development of rickets. The need for simultaneous daily administration of supplements of vitamin D in subjects receiving anticonvulsive drugs is stressed.
Related Concept Videos
Introduction to Electrolytes
Role of Sodium
One...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Serum Studies: Renal Function Tests

